Retatrutide: The Triple Agonist Changing How Clinicians Think About Obesity Medicine
Published on: 21/05/2026
Retatrutide is still investigational. Long-term safety data is still needed, along with more research, and more clinical experience. However, medicine is entering a completely different era of metabolic treatment.
Peptide




